Cargando…
β1-adrenergic receptor stimulation by agonist Compound 49b restores insulin receptor signal transduction in vivo
PURPOSE: Determine whether Compound 49b treatment ameliorates retinal changes due to the lack of β2-adrenergic receptor signaling. METHODS: Using retinas from 3-month-old β2-adrenergic receptor-deficient mice, we treated mice with our novel β1-/β2-adrenergic receptor agonist, Compound 49b, to assess...
Autores principales: | Jiang, Youde, Zhang, Qiuhua, Ye, Eun-Ah, Steinle, Jena J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067233/ https://www.ncbi.nlm.nih.gov/pubmed/24966659 |
Ejemplares similares
-
Etanercept restores normal insulin signal transduction in β2-adrenergic receptor knockout mice
por: Jiang, Youde, et al.
Publicado: (2014) -
β-adrenergic receptor agonist, Compound 49b, inhibits TLR4 signaling pathway in diabetic retina
por: Berger, Elizabeth A., et al.
Publicado: (2016) -
Intravitreal Injection of IGFBP-3 Restores Normal Insulin Signaling in Diabetic Rat Retina
por: Jiang, Youde, et al.
Publicado: (2014) -
Compound 49b Restores Retinal Thickness and Reduces Degenerate Capillaries in the Rat Retina following Ischemia/Reperfusion
por: Liu, Li, et al.
Publicado: (2016) -
β2-Adrenergic Receptor Knockout Mice Exhibit A Diabetic Retinopathy Phenotype
por: Jiang, Youde, et al.
Publicado: (2013)